Healthcare Resource Utilization, Healthcare Costs, and Dose Escalation in Psoriasis Patients Initiated on Ustekinumab versus Adalimumab: A Retrospective Claim Study
Journal of Dermatological Treatment, 2016 10: 1-23. doi: 10.1080/09546634.2016.1247946
Authors
Wu JJ, Guerin A, Gauthier G, Sundaram M